drugset / Trial / NCT00023790

Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

NCT00023790 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. This may be effective treatment for skin cancer and cancer that is metastatic to the skin. PURPOSE: Phase I trial to study the effectiveness of photodynamic therapy in treating patients who have either squamous cell or basal cell carcinoma of the skin or solid tumors metastatic to the skin.

Timeline

Start
2001-08
Primary completion
2005-12
Completion
2006-02

Outcome

Outcome not reported

Stopped (Enrollment): “slow accrual”

Drugs

EvaluationDrugModalityDoseRoute
Subject silicon phthalocyanine 4 Unknown — Intravenous